Evidence map›Paper›PMID 28890672›Full record

ArticleMetabolomics : Official journal of the Metabolomic Society2017

Multivariate strategy for the sample selection and integration of multi-batch data in metabolomics.

Izabella Surowiec, Erik Johansson, Frida Torell, Helena Idborg, Iva Gunnarsson, Elisabet Svenungsson, Per-Johan Jakobsson, Johan Trygg

Abstract read
In one paragraph

Article in Metabolomics : Official journal of the Metabolomic Society, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Izabella SurowiecComputational Life Science Cluster (CLiC), Department of Chemistry, Umeå University, 901 81 Umeå, Sweden.
Erik JohanssonSartorius Stedim Data Analytics AB, 907 19 Umeå, Sweden.
Frida TorellComputational Life Science Cluster (CLiC), Department of Chemistry, Umeå University, 901 81 Umeå, Sweden.
Helena IdborgRheumatology Unit, Department of Medicine, Solna, Karolinska Institutet, Karolinska University Hospital, 171 76 Stockholm, Sweden.
Iva GunnarssonRheumatology Unit, Department of Medicine, Solna, Karolinska Institutet, Karolinska University Hospital, 171 76 Stockholm, Sweden.
Elisabet SvenungssonRheumatology Unit, Department of Medicine, Solna, Karolinska Institutet, Karolinska University Hospital, 171 76 Stockholm, Sweden.
Per-Johan JakobssonRheumatology Unit, Department of Medicine, Solna, Karolinska Institutet, Karolinska University Hospital, 171 76 Stockholm, Sweden.
Johan TryggComputational Life Science Cluster (CLiC), Department of Chemistry, Umeå University, 901 81 Umeå, Sweden.ORCID 0000-0003-3799-6094

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAvailability of large cohorts of samples with related metadata provides scientists with extensive material for studies. At the same time, recent development of modern high-throughput 'omics' technologies, including metabolomics, has resulted in the potential for analysis of large sample sizes. Representative subset selection becomes critical for selection of samples from bigger cohorts and their division into analytical batches. This especially holds true when relative quantification of compound levels is used.

objectivesWe present a multivariate strategy for representative sample selection and integration of results from multi-batch experiments in metabolomics.

methodsMultivariate characterization was applied for design of experiment based sample selection and subsequent subdivision into four analytical batches which were analyzed on different days by metabolomics profiling using gas-chromatography time-of-flight mass spectrometry (GC-TOF-MS). For each batch OPLS-DA

resultsA combined, representative metabolic profile describing differences between systemic lupus erythematosus (SLE) patients and controls was obtained and used for elucidation of metabolic pathways that could be disturbed in SLE.

conclusionDesign of experiment based representative sample selection ensured diversity and minimized bias that could be introduced at this step. Combined metabolic profile enabled unified analysis and interpretation.

Indexed as

MetabolomicsMulti-batch analysisOPLSRepresentative sample selection

Identifiers

PMID28890672
PMCPMC5570768

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.